Konferenzschrift | Kongress
Tissue specific estrogen action : novel mechanisms, novel ligands, novel therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783540495475
3540495479
- Maße
-
22 cm
- Umfang
-
XV, 181 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Literaturangaben
- Erschienen in
-
Ernst Schering Foundation symposium proceedings / Schering Stiftung ; 2006,1
- Schlagwort
-
Gewebestoffwechsel
Östrogene
Hormonsekretion
Plesiokrinie
Signaltransduktion
Histologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin, Heidelberg, New York
- (wer)
-
Springer
- (wann)
-
2007
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzschrift
- Kongress
Beteiligte
- Korach, Kenneth S.
- Springer
Entstanden
- 2007
Ähnliche Objekte (12)
Novel regional therapies for liver tumors
Development of novel parvovirus-based anticancer therapies
Identification of novel TAM receptor interacting proteins : Screening for novel ligands
Estrogen synthesis and novel mechanisms of estrogen action in the developing brain
Estrogen synthesis and novel mechanisms of estrogen action in the developing brain
Novel therapies for meningiomas in vitro and in vivo
Novel therapies for graft versus host disease with a focus on cell therapies
Novel Borane- and Phosphorane- Functionalized Anionic Carbene Ligands
Bis(pyrazolyl)methane ligands for novel tyrosinase models
Modeling of LMNA-cardiomyopathy in human iPSC- derived engineered heart tissue for testing novel therapies
Human molybdenum cofactor biosynthesis and defiency : novel fuctions and therapies
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Novel regional therapies for liver tumors
Development of novel parvovirus-based anticancer therapies
Identification of novel TAM receptor interacting proteins : Screening for novel ligands
Estrogen synthesis and novel mechanisms of estrogen action in the developing brain
Estrogen synthesis and novel mechanisms of estrogen action in the developing brain
Novel therapies for meningiomas in vitro and in vivo
Novel therapies for graft versus host disease with a focus on cell therapies
Novel Borane- and Phosphorane- Functionalized Anionic Carbene Ligands
Bis(pyrazolyl)methane ligands for novel tyrosinase models
Modeling of LMNA-cardiomyopathy in human iPSC- derived engineered heart tissue for testing novel therapies
Human molybdenum cofactor biosynthesis and defiency : novel fuctions and therapies
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Novel regional therapies for liver tumors
Development of novel parvovirus-based anticancer therapies
Identification of novel TAM receptor interacting proteins : Screening for novel ligands
Estrogen synthesis and novel mechanisms of estrogen action in the developing brain
Estrogen synthesis and novel mechanisms of estrogen action in the developing brain
Novel therapies for meningiomas in vitro and in vivo
Novel therapies for graft versus host disease with a focus on cell therapies
Novel Borane- and Phosphorane- Functionalized Anionic Carbene Ligands
Bis(pyrazolyl)methane ligands for novel tyrosinase models
Modeling of LMNA-cardiomyopathy in human iPSC- derived engineered heart tissue for testing novel therapies
Human molybdenum cofactor biosynthesis and defiency : novel fuctions and therapies